A pharmacokinetic-pharmacodynamic model for a muscle relaxant: Atracurium

European Journal of Clinical Pharmacology

Volumn 49, Issue 4, 1996, Pages 325-332

  Nigrovic, V ^a   Gaspari, J ^a   Banoub, M ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Atracurium; Effect compartment; Muscle relaxants; Pharmacokinetic pharmacodynamic model

Indexed keywords

ATRACURIUM; DRUG METABOLITE; LAUDANOSINE; MUSCLE RELAXANT AGENT;

ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0030068726     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00226335     Document Type: Article

References (15)

1. Agoston S, Vandenbrom RHG, Wierda JMKH (1992) Clinical pharmacokinetics of neuromuscular blocking drugs. Clin Pharmacokinet 22:94-115
2. Amaki Y, Waud BE, Waud DR (1985) Atracurium-receptor kinetics: simple behavior from a mixture. Anesth Analg 64: 777-780
3. Bartkowski RB, Epstein RH (1992) The influence of receptor binding on the onset of neuromuscular blockade. Anesthesiology 77:A916
4. Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE (1982) Clinical pharmacology of atracurium besylate (BW 33A): a new nondepolarizing muscle relaxant. Anesth Analg 61:723-729
5. Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn, Dekker, New york
6. Henthorn TK, Avram MJ, Krejcie TC, Shanks CA, Asada A, Kaezynski DA (1992) Minimal compartmental model of circulatory mixing of indocyanine green. Am J Physiol 262:H903-H910
7. Holford NHG, Sheiner LB (1981) Pharmacokinetic and pharmacodynamic modeling in vivo. CRC Critical Rev Bioeng 5:273-322
8. Hull CJ, Van Beem HBH, McLeod K, Sibbald A, Watson MJ (1978) A pharmacodynamic model for pancuronium. Br J Anaesth 50:1113-1123
9. Kent AP, Parker CJR, Hunter JM (1989) Pharmacokinetics of atracurium and laudanosine in the elderly. Br J Anaesth 63:661-666
10. Nigrovic V, Banoub M (1992) Pharmacokinetic modelling of a parent drug and its metabolite. Clin Pharmacokinet 22: 396-408
11. Parker CJR, Hunter JM (1992) A new four-parameter threshold model for the plasma atracurium concentration-response relationship. Br J Anaesth 68:548-554
12. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25:358-371
13. Stirt A, Murray AL, Katz RL, Schehl DL, Lee C (1983) Atracurium during halothane anesthesia in humans. Anesth Analg 62:207-210
14. Tsui D, Graham GG, Torda TA (1987) The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 67:722-728
15. Weatherley B, Williams SG, Neill EAM (1983) Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v. Br J Anaesth 55:39S-45S